Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
80.22 USD | +0.84% | +3.93% | +4.11% |
May. 06 | Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating | MT |
May. 02 | UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.11% | 12.55B | |
+19.44% | 47.02B | |
+48.77% | 41.86B | |
+0.31% | 41.76B | |
-4.27% | 28.8B | |
+11.74% | 26.05B | |
-21.89% | 19.15B | |
+29.32% | 12.34B | |
-3.76% | 11.82B | |
+20.68% | 11.8B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Transcript : Bio-Techne Corporation, Q2 2024 Earnings Call, Feb 01, 2024